Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Public ClinicalTrials.gov record NCT01622348. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate different dose levels of IMO-3100 compared to placebo administered for 4 weeks to patients with moderate to severe plaque psoriasis.
Study identification
- NCT ID
- NCT01622348
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 44 participants
Conditions and interventions
Interventions
- IMO-3100 at 0.16 mg/kg Drug
- Saline for Injection Drug
- IMO-3100 at 0.32 mg/kg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2012 (Type not available)
- Primary completion
- Nov 2012 (Actual)
- Completion
- Dec 2012 (Actual)
- Last update posted
- Jan 9, 2018
2012
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Florida Center for Dermatology, P.A | Jacksonville | Florida | 32204 | — |
| Atlanta Dermatology, Vein & Research Center, PC | Alpharetta | Georgia | 30022 | — |
| Dermatologic Surgery Specialists, Inc. | Macon | Georgia | 31217 | — |
| Indiana Clinical Trials Center, PC | Plainfield | Indiana | 46168 | — |
| DermResearch PLLC | Louisville | Kentucky | 40217 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| Mass General Hospital Clinical Unit for Research Trials in Skin | Boston | Massachusetts | 02199 | — |
| Derm Research Center of New York | Stony Brook | New York | 11790 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| Clinical Partners, Inc | Johnston | Rhode Island | 02919 | — |
| J & S Studies | College Station | Texas | 77845 | — |
| Center for Clinical Studies | Webster | Texas | 77598 | — |
| University of Utah, Dermatology | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01622348, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 9, 2018 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01622348 live on ClinicalTrials.gov.